Zhang MY, Zhao Y, Liu JF, Liu GP, Zhang RY, Wang LM. Efficacy of different antibiotics in treatment of children with respiratory mycoplasma infection. World J Clin Cases 2021; 9(23): 6717-6724 [PMID: 34447818 DOI: 10.12998/wjcc.v9.i23.6717]
Corresponding Author of This Article
Li-Min Wang, PhD, Staff Physician, Department of Pediatrics, Qingdao Municipal Hospital, No. 1 Jiaozhou Road, Shibei District, Qingdao 266011, Shandong Province, China. wanglimin1020@126.com
Research Domain of This Article
Respiratory System
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Aug 16, 2021; 9(23): 6717-6724 Published online Aug 16, 2021. doi: 10.12998/wjcc.v9.i23.6717
Table 1 Baseline data comparison between the clarithromycin group and the erythromycin group, n (%)
Baseline data
Clarithromycin group (n = 53)
Erythromycin group (n = 53)
χ2/t
P value
Gender
0.641
0.423
Male
28 (52.83)
29 (54.72)
Female
25 (47.17)
24 (45.28)
School
Kindergarten
11 (20.75)
10 (18.87)
0.111
0.739
Primary school
38 (71.70)
37 (69.81)
0.086
0.769
Junior high school
4 (7.55)
6 (11.32)
0.832
0.362
Age
6.74 (1.25)
6.83 (1.22)
1.050
0.862
Table 2 Comparison of the total clinical effectiveness in the clarithromycin group and the erythromycin group, n (%)
Group
Number of cases
Invalid
Effective
Marked effect
Total clinical effectiveness
Clarithromycin group
53
2 (3.77)
19 (35.85)
32 (60.38)
51 (96.23)
Erythromycin group
53
13 (24.53)
22 (41.51)
18 (33.96)
40 (75.47)
χ2
-
17.739
0.675
14.005
17.739
P value
-
0.001
0.411
0.001
0.001
Table 3 Hospital stay time, drug cost, and antipyretic time of the clarithromycin group vs the erythromycin group (mean ± SD)
Clarithromycin group (n = 53)
Erythromycin group (n = 53)
t
P value
Hospital stays (d)
15.14 ± 2.01)
20.63 ± 3.15
10.696
0.001
Drug cost (Yuan)
1654.63 ± 100.21
2152.14 ± 163.48
18.889
0.001
Antipyretic time (d)
2.63 ± 0.57
4.06 ± 0.75
11.051
0.001
Table 4 Toxic side effects of the clarithromycin group compared with the erythromycin group, n (%)
Group
Number of cases
Stomach ache
Diarrhea
Nausea
Other
Incidence of side effects
Clarithromycin group
53
2 (3.77)
1 (1.89)
2 (3.77)
3 (5.66)
8 (15.09)
Erythromycin group
53
8 (15.09)
7 (13.21)
10 (18.87)
11 (20.75)
36 (67.92)
χ2
-
7.502
9.179
11.357
9.934
57.479
P value
-
0.006
0.002
0.001
0.002
0.001
Table 5 Comparison of medication compliance between the clarithromycin group and the erythromycin group, n (%)
Group
Number of cases
Full compliance
Obey
Disobey
Medication compliance
Clarithromycin group
53
40 (81.13)
12 (22.64)
1 (1.89)
52 (98.11)
Erythromycin group
53
18 (33.96)
20 (37.74)
15 (28.30)
38 (71.70)
χ2
-
45.537
5.409
27.211
27.211
P value
-
0.001
0.020
0.001
0.001
Citation: Zhang MY, Zhao Y, Liu JF, Liu GP, Zhang RY, Wang LM. Efficacy of different antibiotics in treatment of children with respiratory mycoplasma infection. World J Clin Cases 2021; 9(23): 6717-6724